176 related articles for article (PubMed ID: 10825390)
1. Identification and molecular characterization of rat CXCR3: receptor expression and interferon-inducible protein-10 binding are increased in focal stroke.
Wang X; Li X; Schmidt DB; Foley JJ; Barone FC; Ames RS; Sarau HM
Mol Pharmacol; 2000 Jun; 57(6):1190-8. PubMed ID: 10825390
[TBL] [Abstract][Full Text] [Related]
2. Cloning of the murine interferon-inducible protein 10 (IP-10) receptor and its specific expression in lymphoid organs.
Tamaru M; Tominaga Y; Yatsunami K; Narumi S
Biochem Biophys Res Commun; 1998 Oct; 251(1):41-8. PubMed ID: 9790904
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H
Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
[TBL] [Abstract][Full Text] [Related]
5. Effects of overexpression of CXCL10 (cytokine-responsive gene-2) on MA-10 mouse Leydig tumor cell steroidogenesis and proliferation.
Nagpal ML; Chen Y; Lin T
J Endocrinol; 2004 Dec; 183(3):585-94. PubMed ID: 15590984
[TBL] [Abstract][Full Text] [Related]
6. I-TAC/CXCL11 is a natural antagonist for CCR5.
Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B
J Leukoc Biol; 2004 Sep; 76(3):701-8. PubMed ID: 15178708
[TBL] [Abstract][Full Text] [Related]
7. Antagonist of interferon-inducible protein 10/CXCL10 ameliorates the progression of autoimmune sialadenitis in MRL/lpr mice.
Hasegawa H; Inoue A; Kohno M; Muraoka M; Miyazaki T; Terada M; Nakayama T; Yoshie O; Nose M; Yasukawa M
Arthritis Rheum; 2006 Apr; 54(4):1174-83. PubMed ID: 16575871
[TBL] [Abstract][Full Text] [Related]
8. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes.
Kawada K; Sonoshita M; Sakashita H; Takabayashi A; Yamaoka Y; Manabe T; Inaba K; Minato N; Oshima M; Taketo MM
Cancer Res; 2004 Jun; 64(11):4010-7. PubMed ID: 15173015
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis.
Okamoto Y; Folco EJ; Minami M; Wara AK; Feinberg MW; Sukhova GK; Colvin RA; Kihara S; Funahashi T; Luster AD; Libby P
Circ Res; 2008 Feb; 102(2):218-25. PubMed ID: 17991878
[TBL] [Abstract][Full Text] [Related]
10. Identification of potent and selective RNA antagonists of the IFN-gamma-inducible CXCL10 chemokine.
Marro ML; Daniels DA; McNamee A; Andrew DP; Chapman TD; Jiang MS; Wu Z; Smith JL; Patel KK; Gearing KL
Biochemistry; 2005 Jun; 44(23):8449-60. PubMed ID: 15938634
[TBL] [Abstract][Full Text] [Related]
11. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3.
Cole KE; Strick CA; Paradis TJ; Ogborne KT; Loetscher M; Gladue RP; Lin W; Boyd JG; Moser B; Wood DE; Sahagan BG; Neote K
J Exp Med; 1998 Jun; 187(12):2009-21. PubMed ID: 9625760
[TBL] [Abstract][Full Text] [Related]
12. Expression of CXC chemokine IP-10 in testicular germ cell tumours.
Schweyer S; Soruri A; Baumhoer D; Peters J; Cattaruzza M; Radzun HJ; Fayyazi A
J Pathol; 2002 May; 197(1):89-97. PubMed ID: 12081209
[TBL] [Abstract][Full Text] [Related]
13. Identification of CCR8 as the specific receptor for the human beta-chemokine I-309: cloning and molecular characterization of murine CCR8 as the receptor for TCA-3.
Goya I; Gutiérrez J; Varona R; Kremer L; Zaballos A; Márquez G
J Immunol; 1998 Feb; 160(4):1975-81. PubMed ID: 9469461
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation.
Xanthou G; Williams TJ; Pease JE
Eur J Immunol; 2003 Oct; 33(10):2927-36. PubMed ID: 14515277
[TBL] [Abstract][Full Text] [Related]
15. Chemokine and receptor-gene expression during early and late acute rejection episodes in human cardiac allografts.
Fahmy NM; Yamani MH; Starling RC; Ratliff NB; Young JB; McCarthy PM; Feng J; Novick AC; Fairchild RL
Transplantation; 2003 Jun; 75(12):2044-7. PubMed ID: 12829909
[TBL] [Abstract][Full Text] [Related]
16. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.
De Paepe B; De Keyzer K; Martin JJ; De Bleecker JL
Acta Neuropathol; 2005 Jun; 109(6):576-82. PubMed ID: 15937690
[TBL] [Abstract][Full Text] [Related]
17. Early up-regulation of CXC-chemokine expression is associated with strong cellular immune responses to murine skin xenografts.
Lee EM; Park JO; Kim D; Kim JY; Oh KH; Park CG; Oh BH; Kim S; Ahn C
Xenotransplantation; 2006 Jul; 13(4):328-36. PubMed ID: 16768726
[TBL] [Abstract][Full Text] [Related]
18. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice.
Wareing MD; Lyon AB; Lu B; Gerard C; Sarawar SR
J Leukoc Biol; 2004 Oct; 76(4):886-95. PubMed ID: 15240757
[TBL] [Abstract][Full Text] [Related]
19. A functional IFN-gamma-inducible protein-10/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan.
Soejima K; Rollins BJ
J Immunol; 2001 Dec; 167(11):6576-82. PubMed ID: 11714827
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of secretory leukocyte protease inhibitor (SLPI) in the brain after ischemic stroke: adenoviral expression of SLPI protects brain from ischemic injury.
Wang X; Li X; Xu L; Zhan Y; Yaish-Ohad S; Erhardt JA; Barone FC; Feuerstein GZ
Mol Pharmacol; 2003 Oct; 64(4):833-40. PubMed ID: 14500739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
